Gilead Sciences Inc (BUE:GILD)
ARS 26600 125 (0.47%) Market Cap: 111.51 Tn Enterprise Value: 131.94 Tn PE Ratio: 110.08 PB Ratio: 6.15 GF Score: 52/100

Gilead Sciences Inc Annual Shareholders Meeting Transcript

May 12, 2021 / 05:00PM GMT
Release Date Price: ARS2664.5 (+0.97%)
Operator

Welcome to the Gilead Sciences, Inc. 2021 Annual Meeting of Stockholders.

I would now like to turn -- I would now like to introduce you to Daniel O'day.

Daniel P. O;Day
Gilead Sciences, Inc. - Chairman & CEO

' -

Good morning. I'm Dan O'Day, Chairman of the Board and Chief Executive Officer of Gilead Sciences. I'm pleased to welcome you to Gilead's 2021 Annual Meeting of Stockholders.

Due to the COVID-19 pandemic and to support the health and safety of our stockholders, employees, Board of Directors and surrounding communities, we are holding this meeting in a virtual-only format instead of as in-person meeting.

We have stockholders and participants attending via the virtual meeting portal. Before I call the meeting to order, I'd like to introduce you to some of the members of the Gilead team.

Joining me today are the members of the Board of Directors. Kevin Lofton, our Lead Independent Director; Jacqueline Barton; Jeffrey Bluestone; Sandra Horning; Kelly Kramer; Harish Manwani; Javier Rodriguez; Anthony

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot